4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063795
Chief Legal Officer gave up 306 shares (to pay taxes)
- Chief Legal Officer acquired 1,075 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2018-12-18 | Option exercise | +1,075 | 79,951 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2018-12-18 | Shares withheld for taxes | −306 | $6.30 | $1,928 | 79,645 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2018-12-18 | Option exercise · Restricted Stock Units | −1,075 | 1,075 | D | ||
Loading xslF345X03/doc4.xml…